Provided by Tiger Fintech (Singapore) Pte. Ltd.

Range Cancer Therapeutics ETF

9.02
0.0000
Volume:- -
Turnover:- -
Market Cap:7.04M
PE:23.74
High:9.02
Open:9.02
Low:9.02
Close:9.02
Loading ...

Company Profile

Company Name:
Range Cancer Therapeutics ETF
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund’s total assets will be invested in the component securities of the index.